Advertisement: Simpsons Creative
Advertisement: RSM mid banner
Advertisement: CJBS mid banner
Advertisement: partnersand mid banner
Cambridgeand mid banner advertisement
Barr Ellison Solicitors – commercial property
Advertisement: Kao Data Centre mid banner
Advertisement: Bar Ellison mid banner property
Advertisement: EBCam mid banner
ARM Innovation Hub
Advertisement mid banner S-Tech 1
Advertisement: Cambridge Network mid banner
Advertisement: Excalibur Healthcare mid banner
Advertisement: Mogrify mid banner
Mid banner advertisement: BDO
Advertisement: HCR Hewitsons mid banner
Advertisement: SATAVIA mid banner
18 January, 2022 - 12:18 By Tony Quested

PhoreMost scales into new Cambridge HQ

Biopharma specialist PhoreMost has relocated its UK headquarters to Unity Campus, a high-spec technology and innovation park owned by Howard Group in south Cambridge.

Designed to support PhoreMost’s phenotypic screening requirements and expertise, the new bespoke 14,900 sq ft state-of-the-art facility is split equally between office and laboratory space with an additional 4,000 sq ft of warehouse storage. 

The space, within The Works, Unity Campus’ latest combined office and R & D building, enables the company to add in-house flow cytometry and imaging capabilities. 

Nearly doubling the size of its previous facilities, the relocation accommodates PhoreMost’s accelerated expansion and ongoing recruitment efforts within one location, including the recent appointment of Dr Christian Dillon as chief scientific officer.

Based within the South Cambridge Science Cluster, PhoreMost’s relocation to Unity Campus places the company in close proximity to numerous innovative life science and technology organisations, opening up opportunities for further collaborations with potential partners and researchers based at the campus.

CEO Dr Chris Torrance said: “Our move to Unity Campus follows a significant year for the company, including a successful £33 million Series B investment round in March 2021. 

“As a team, remaining within the Cambridge biotech cluster is important, to help fuel new strategic collaborations, and support those already in progress. This move brings the whole team together in one site, where previously we were split across two buildings. 

“With further space available at Unity Campus we are well positioned to continue to advance and expand our drug discovery programmes across high value, but under-served, therapeutic areas.”

Katherine Friend, director for Investment & Asset Management at Howard Group, added: “The relocation of PhoreMost’s headquarters to Unity Campus exemplifies the specialist network of innovative, agile, science and technology organisations we are establishing here. 

“We have thoroughly enjoyed working with the PhoreMost team to tailor their new laboratory and office space within The Works and are excited to welcome them at such a pivotal time in the company’s development.”

Having completed The Works in 2020, the second phase of Howard Group’s re-development of Unity Campus is now being brought forward. In response to market demand for agile, flexible science space, Phase 2 will consist of three buildings – totalling 95,000 sq ft – all specifically designed to provide high quality accommodation for life science occupiers.

Each building will consist of ground, first and second floor office and laboratory accommodation, with landlord plant provision above. 

Subject to planning, it is anticipated that Phase 2 will be available from Q1 2023 with units from 10,000 sq ft now available for pre-let. Howard Group welcomes enquiries from potential occupiers wishing to engage at this early stage to enable bespoke requirements to be taken into account.

As well as Phoremost, life sciences occupiers at Unity Campus include Aqdot, IONTAS, Liminal Bioscience and Sareum.

Newsletter Subscription

Stay informed of the latest news and features